Cell Impact Q3 2025: Positioned to gear up for future business
Cell Impact has gradually improved the ability to scale up production. After the end of the quarter, the company announced a transaction that marked that the project had transitioned to continuous production.Sales in the third quarter remained weak. Net sales totalled SEK 0.4 million (5.5). Earnings for the quarter remained negative at SEK –21.7 million. Cell Impact’s long-term efforts have led to a gradual improvement in the ability to scale up production. - After the end of the quarter, we announced a transaction that marked our exit from the development phase of the project in
